The Sequester and the FDA | GenomeWeb

While the US Food and Drug Administration has been working to speed up the time it takes for drugs to garner approval, Commissioner Margaret Hamburg says that the sequester may slow those efforts, the Boston Herald reports. Speaking to the Massachusetts Biotechnology Council annual meeting attendees, Hamburg added that she would like Congress to allow FDA to access the user fees it collects to pay for its operating costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.